Behavioral Health Providers

Aims to promote awareness for the evidence base and promise of motivational interventions and shows how clinicians can influence motivation by developing a therapeutic relationship with the client. Describes different motivational interventions that can be used at all stages of change.

Describes the core elements of SBIRT programs and provides general administrative and managerial information relevant to implementing SBIRT services, including effectiveness, implementation models, challenges and barriers to implementation, issues of cost and sustainability, real-life program anecdotes, and case studies.

Provides substance abuse treatment providers with updated information on co-occurring substance use and mental disorders and advances in treatment for people with co-occurring disorders. Discusses terminology, assessment, and treatment strategies and models.

Includes Federal resources for rural communities organized in 26 overarching categories to help address substance use disorder and opioid misuse

Details a checklist for providers to use when determining if a patient meets the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, criteria for a diagnosis of opioid use disorder.

Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.

Identifies patient problems and concerns attributed to use of opioids, rather than focusing on aberrant behaviors.

Assesses known opioid-related overdose risk behaviors.

Assesses for SUD risk among adolescents 12-17 years old.

Provides electronic screening tools for adolescent substance use that triage adolescents ages 12-17 into three levels of risk for SUD based on their report of past year use: no reported use, lower risk, and higher risk.